Article
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Mar 2009
Tao Meng Hua, Shields Peter G, Nie Jing, Marian Catalin, Ambrosone Christine B, McCann Susan E, Platek Mary, Krishnan Shiva S, Xie Bin, Edge Stephen B, Winston Janet, Vito Dominica, Trevisan Maurizio, Freudenheim Jo L
Abstract excerpt
Aberrant promoter methylation is recognized as an important feature of breast carcinogenesis. We hypothesized that genetic variation of genes for methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MTR), two critical enzymes in the one-carbon metabolism, may alter DNA methylation levels and thus influence DNA methylation in breast cancer. We evaluated case-control association of MTHFR C677T,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
